The apoptosis inhibitory domain of FE65-like protein 1 regulates both apoptotic and caspase-independent programmed cell death mediated by tumor necrosis factor

Biochemical and Biophysical Research Communications

Volumn 335, Issue 2, 2005, Pages 575-583

  Lange, Arne ^a   Thon, Lutz ^a   Mathieu, Sabine ^a   Adam, Dieter ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Apoptosis; Caspase independent programmed cell death; Ceramide; FE65 like; Tumor necrosis factor

Indexed keywords

ANTIOXIDANT; BUTYLATED HYDROXYANISOLE; CASPASE; CERAMIDE; COMPLEMENTARY DNA; PROTEIN FE65; REACTIVE OXYGEN METABOLITE; SPHINGOLIPID; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CONTROLLED STUDY; FIBROSARCOMA; GENE CLUSTER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BASE SEQUENCE; CASPASES; CELL DEATH; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CERAMIDES; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC VECTORS; HUMANS; IMMUNOBLOTTING; MICE; MOLECULAR SEQUENCE DATA; NITROSOGUANIDINES; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, TERTIARY; REACTIVE OXYGEN SPECIES; SEQUENCE HOMOLOGY, AMINO ACID; SPHINGOLIPIDS; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 23744459810     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.07.125     Document Type: Article

References (31)

1. M. Leist, and M. Jäättelä Four deaths and a funeral: from caspases to alternative mechanisms Nat. Rev. Mol. Cell Biol. 2 2001 589 598
2. R.W. Johnstone, A.A. Ruefli, and S.W. Lowe Apoptosis: a link between cancer genetics and chemotherapy Cell 108 2002 153 164
3. M. Jäättelä Multiple cell death pathways as regulators of tumour initiation and progression Oncogene 23 2004 2746 2756
4. A. Cauwels, B. Janssen, A. Waeytens, C. Cuvelier, and P. Brouckaert Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2 Nat. Immunol. 4 2003 387 393
5. M. Jäättelä, and J. Tschopp Caspase-independent cell death in T lymphocytes Nat. Immunol. 4 2003 416 423
6. G. Denecker, D. Vercammen, M. Steemans, T. Vanden Berghe, G. Brouckaert, G. van Loo, B. Zhivotovsky, W. Fiers, J. Grooten, W. Declercq, and P. Vandenabeele Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria Cell Death Differ. 8 2001 829 840
7. N. Holler, R. Zaru, O. Micheau, M. Thomé, A. Attinger, S. Valitutti, J.L. Bodmer, P. Schneider, B. Seed, and J. Tschopp Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule Nat. Immunol. 1 2000 489 495
8. A. Strelow, K. Bernardo, S. Adam-Klages, T. Linke, K. Sandhoff, M. Krönke, and D. Adam Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death J. Exp. Med. 192 2000 601 611
9. D. Vercammen, R. Beyaert, G. Denecker, V. Goossens, G. van Loo, W. Declercq, J. Grooten, W. Fiers, and P. Vandenabeele Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor J. Exp. Med. 187 1998 1477 1485
10. S. Lüschen, S. Ussat, G. Scherer, D. Kabelitz, and S. Adam-Klages Sensitization to death receptor cytotoxicity by inhibition of Fas-associated death domain protein (FADD)/caspase signaling-requirement of cell cycle progression J. Biol. Chem. 275 2000 24670 24678
11. L Biochem. Biophys. Res. Commun. 227 1996 266 272
12. H. Cao, N. Pratt, J. Mattison, Y. Zhao, and N.S. Chang Characterization of an apoptosis inhibitory domain at the C-termini of FE65-like protein Biochem. Biophys. Res. Commun. 276 2000 843 850
13. Q. Hu, L. Wang, Z. Yang, B.H. Cool, G. Zitnik, and G.M. Martin Endoproteolytic cleavage of FE65 converts the adaptor protein to a potent suppressor of the sAPPalpha pathway in primates J. Biol. Chem. 280 2005 12548 12558
14. P. Bruni, G. Minopoli, T. Brancaccio, M. Napolitano, R. Faraonio, N. Zambrano, U. Hansen, and T. Russo Fe65, a ligand of the Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression J. Biol. Chem. 277 2002 35481 35488
15. A. Duilio, R. Faraonio, G. Minopoli, N. Zambrano, and T. Russo Fe65L2: a new member of the Fe65 protein family interacting with the intracellular domain of the Alzheimer's beta-amyloid precursor protein Biochem. J. 330 1998 513 519
16. R. Schwandner, K. Wiegmann, K. Bernardo, D. Kreder, and M. Krönke TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase J. Biol. Chem. 273 1998 5916 5922
17. S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D.J. Lipman Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acids Res. 25 1997 3389 3402
18. N. Zambrano, M. Bimonte, S. Arbucci, D. Gianni, T. Russo, and P. Bazzicalupo feh-1 and apl-1, the Caenorhabditis elegans orthologues of mammalian Fe65 and beta-amyloid precursor protein genes, are involved in the same pathway that controls nematode pharyngeal pumping J. Cell Sci. 115 2002 1411 1422
19. H. Tanahashi, and T. Tabira Characterization of an amyloid precursor protein-binding protein Fe65L2 and its novel isoforms lacking phosphotyrosine-interaction domains Biochem. J. 367 2002 687 695
20. N. Zambrano, G. Minopoli, P. de Candia, and T. Russo The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1 J. Biol. Chem. 273 1998 20128 20133
21. M.S. Perkinton, C.L. Standen, K.F. Lau, S. Kesavapany, H.L. Byers, M. Ward, D.M. McLoughlin, and C.C. Miller The c-Abl tyrosine kinase phosphorylates the Fe65 adaptor protein to stimulate Fe65/amyloid precursor protein nuclear signaling J. Biol. Chem. 279 2004 22084 22091
22. C.L. Standen, M.S. Perkinton, H.L. Byers, S. Kesavapany, K.F. Lau, M. Ward, D. McLoughlin, and C.C. Miller The neuronal adaptor protein Fe65 is phosphorylated by mitogen-activated protein kinase (ERK1/2) Mol. Cell. Neurosci. 24 2003 851 857
23. J.M. Ostrove, and G.E. Gifford Stimulation of RNA synthesis in L-929 cells by rabbit tumor necrosis factor Proc. Soc. Exp. Biol. Med. 160 1979 354 358
24. L.A. Tartaglia, and D.V. Goeddel Two TNF receptors Immunol. Today 13 1992 151 153
25. S.W. Yu, H.M. Wang, M.F. Poitras, C. Coombs, W.J. Bowers, H.J. Federoff, G.G. Poirier, T.M. Dawson, and V.L. Dawson Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor Science 297 2002 259 263
26. S. Lüschen, G. Scherer, S. Ussat, H. Ungefroren, and S. Adam-Klages Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-kappaB, elicits caspase activity, and enhances cytotoxicity Exp. Cell. Res. 293 2004 196 206
27. O. Micheau, and J. Tschopp Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes Cell 114 2003 181 190
28. H. Wajant, K. Pfizenmaier, and P. Scheurich Tumor necrosis factor signaling Cell Death Differ. 10 2003 45 65
29. B.J. Pettus, C.E. Chalfant, and Y.A. Hannun Ceramide in apoptosis: an overview and current perspectives Biochim. Biophys. Acta-Mol. Cell Biol. Lipids 1585 2002 114 125
30. R.N. Kolesnick, and M. Krönke Regulation of ceramide production and apoptosis Annu. Rev. Physiol. 60 1998 643 665
31. R. Hurwitz, K. Ferlinz, and K. Sandhoff The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts Biol. Chem. Hoppe-Seyler 375 1994 447 450